Smith & Nephew Warning Letter Details Uncleared Product Modifications
This article was originally published in The Gray Sheet
Executive Summary
A warning letter posted by FDA July 8 provides more details behind Smith & Nephew’s recent announcement that it was temporarily halting sales of its Renasys line of negative pressure wound therapy devices.